[The influence of hepatoprotector 2-ethylthiobenzimidazole hydrobromide (bemithyl) on the content of glycogen in cirrhotic rat liver hepatocytes located in various microenvironments].
Kudriavtseva MV, Bezborodkina NN, Okovityĭ SV, Kudriavtsev BN · 2004 · Tsitologiia; 2004
Study findings
In cirrhotic rat liver, bemithyl-associated glycogen changes differed between hepatocytes within lobules and the wider cell population.
- Population and setting
- Experimental animals or tissue preparations
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Experimental or incompletely specified settings do not establish human efficacy, dosing or safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Kudriavtseva MV, Bezborodkina NN, Okovityĭ SV, Kudriavtsev BN. [The influence of hepatoprotector 2-ethylthiobenzimidazole hydrobromide (bemithyl) on the content of glycogen in cirrhotic rat liver hepatocytes located in various microenvironments]. Tsitologiia; 2004 2004.
Molekul research summary: https://molekul.io/research/bemitil-extra-15598020. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry